More on CNTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/6/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Context Therapeutics (NQ:CNTX)
Delayed: 0.53 +0.02 (3.92%)
Prev. Close $0.51  
Open$0.50 
52 Wk High$ 
52 Wk Low$ 
Day High$0.53 
Day Low$0.49 
P/E N/A  
EPS$ 
Volume887,116 

Friends, Peers and Foes (?): SKYE, NEOG, BCAB, IMNM, ONCY (more...)

Aug 12, 2026 04:31 PM Form SCHEDULE 13G/A Context Therapeutics Filed by: Blue Owl Capital Holdings LP
Aug 6, 2026 02:45 AM Context Therapeutics Inc. (CNTX) Misses Q2 EPS by 6c
Aug 5, 2026 04:21 PM Form 8-K Context Therapeutics For: Aug 05
Aug 5, 2026 04:14 PM Context Therapeutics Reports Second Quarter 2026 Operating and Pipeline Progress
Aug 5, 2026 04:14 PM Form 10-Q Context Therapeutics For: Jun 30
Jul 31, 2026 04:11 PM Context Therapeutics gets Nasdaq minimum bid price deficiency notice
Jul 31, 2026 04:09 PM Form 8-K Context Therapeutics For: Jul 29
Jul 31, 2026 04:01 PM Form SCHEDULE 13G/A Context Therapeutics Filed by: Octagon Capital Advisors LP
Jul 27, 2026 04:27 PM Form SCHEDULE 13G Context Therapeutics Filed by: BlackRock, Inc.
Jul 10, 2026 04:05 PM Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
View All Articles

Entities mentioned with CNTX

View All Entities